Literature DB >> 15788741

Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.

Stefania Gessi1, Katia Varani, Stefania Merighi, Elena Cattabriga, Cecilia Pancaldi, Youri Szabadkai, Rosario Rizzuto, Karl-Norbert Klotz, Edward Leung, Stephen Mac Lennan, Pier Giovanni Baraldi, Pier Andrea Borea.   

Abstract

In this study, we compared the pharmacological and biochemical characteristics of A(2B) adenosine receptors in recombinant (hA(2B)HEK293 cells) and native cells (neutrophils, lymphocytes) by using a new potent 8-pyrazole xanthine derivative, [(3)H]N-benzo[1,3]dioxol-5-yl-2-[5-(1,3-dipropyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl-oxy]-acetamide] ([(3)H]MRE 2029-F20), that has high affinity and selectivity for hA(2B) versus hA(1),hA(2A), and hA(3) subtypes. [(3)H]MRE 2029-F20 bound specifically to the hA(2B) receptor stably transfected in human embryonic kidney (HEK) 293 cells with K(D) of 2.8 +/- 0.2 nM and B(max) of 450 +/- 42 fmol/mg of protein. Saturation experiments of [(3)H]MRE 2029-F20 binding in human neutrophils and lymphocytes detected a single high-affinity binding site with K(D) values of 2.4 +/- 0.5 and 2.7 +/- 0.7 nM, respectively, and B(max) values of 79 +/- 10 and 54 +/- 8 fmol/mg of protein, respectively, in agreement with real-time reverse transcription polymerase chain reaction studies showing the presence of A(2B) mRNA. The rank order of potency of typical adenosine ligands with recombinant hA(2B) receptors was consistent with that typically found for interactions with the A(2B) subtype and was also similar in peripheral blood cells. 5'-N-Ethyl-carboxamidoadenosine stimulated cAMP accumulation in both hA(2B)HEK293 and native cells, whereas phospholipase C activation was observed in recombinant receptors and endogenous subtypes expressed in neutrophils but not in lymphocytes. MRE 2029-F20 was revealed to be a potent antagonist in counteracting the agonist effect in both signal transduction pathways. In conclusion, [(3)H]MRE 2029-F20 is a selective and high-affinity radioligand for the hA(2B) adenosine subtype and may be used to quantify A(2B) endogenous receptors. In this work, we demonstrated their presence and functional coupling in neutrophils and lymphocytes that play a role in inflammatory processes in which A(2B) receptors may be involved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788741     DOI: 10.1124/mol.104.009225

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  15 in total

1.  Adenosine signaling via the adenosine 2B receptor is involved in bronchiolitis obliterans development.

Authors:  Yunge Zhao; Damien J LaPar; John Steidle; Abbas Emaminia; Irving L Kron; Gorav Ailawadi; Joel Linden; Christine L Lau
Journal:  J Heart Lung Transplant       Date:  2010-12       Impact factor: 10.247

2.  Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes.

Authors:  K Varani; F Vincenzi; A Tosi; M Targa; F F Masieri; A Ongaro; M De Mattei; L Massari; P A Borea
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 3.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 4.  Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?

Authors:  V Kumar
Journal:  Purinergic Signal       Date:  2012-12-28       Impact factor: 3.765

Review 5.  Role of adenosine A(2B) receptors in inflammation.

Authors:  Igor Feoktistov; Italo Biaggioni
Journal:  Adv Pharmacol       Date:  2011

6.  Adenosine signaling contributes to ethanol-induced fatty liver in mice.

Authors:  Zhongsheng Peng; Pier Andrea Borea; Katia Varani; Tuere Wilder; Herman Yee; Luis Chiriboga; Michael R Blackburn; Gianfranco Azzena; Giuseppe Resta; Bruce N Cronstein
Journal:  J Clin Invest       Date:  2009-02-16       Impact factor: 14.808

7.  Characterization of human and rodent native and recombinant adenosine A(2B) receptors by radioligand binding studies.

Authors:  Daniela C G Bertarelli; Martina Diekmann; Alaa M Hayallah; Dorothee Rüsing; Jamshed Iqbal; Birgit Preiss; Eugen J Verspohl; Christa E Müller
Journal:  Purinergic Signal       Date:  2006-07-08       Impact factor: 3.765

8.  Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates.

Authors:  Rao V Kalla; Jeff Zablocki
Journal:  Purinergic Signal       Date:  2008-06-21       Impact factor: 3.765

9.  Search for adenosine A2A spare receptors on peripheral human lymphocytes.

Authors:  Laurent Jacquin; Frédéric Franceschi; Youlet By; Josée-Martine Durand-Gorde; Jocelyne Condo; Jean-Claude Deharo; Pierre Michelet; Emmanuel Fenouillet; Régis Guieu; Jean Ruf
Journal:  FEBS Open Bio       Date:  2012-11-17       Impact factor: 2.693

10.  Adenosine and lymphocyte regulation.

Authors:  Stefania Gessi; Katia Varani; Stefania Merighi; Eleonora Fogli; Valeria Sacchetto; Annalisa Benini; Edward Leung; Stephen Mac-Lennan; Pier Andrea Borea
Journal:  Purinergic Signal       Date:  2007-01-16       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.